Mankind Pharma’s Q3 FY25 net profit declined 16% YoY to ₹385 crore despite a 24% revenue increase to ₹3,230 crore. Domestic revenues rose 17%, exports more than doubled, and consumer health grew 30%.
Warburg Pincus to evaluate buying majority stake in Nuvama Wealth: Report
Warburg Pincus may acquire a majority stake in Nuvama Wealth Management as PAG looks to sell its 54% holding, valued at $1.6 billion. JPMorgan and